Literature DB >> 9276523

Expression of lactoferrin on human granulocytes: analysis with polyclonal and monoclonal antibodies.

A Afeltra1, D Caccavo, G M Ferri, M A Addessi, F G De Rosa, A Amoroso, L Bonomo.   

Abstract

Lactoferrin (LF), an iron-binding protein present in specific granules of neutrophils, is expressed on membrane after granulocyte activation. It may represent a target for anti-neutrophil cytoplasmic antibodies (ANCA) in patients affected by some immunomediated diseases. We recently produced two MoAbs, AGM 2.29 and AGM 10.14, that recognize two spatially distant epitopes of human LF. In this study we perform a cytometric analysis in order to evaluate the expression of LF on the surface of granulocytes obtained from freshly drawn blood or after purification, in both the presence and absence of stimuli. Our results demonstrate that LF is not constitutively expressed on membrane of circulating neutrophils. After priming with phorbol myristate acetate (PMA) or tumour necrosis factor-alpha (TNF-alpha), an increased mean fluorescence intensity (MFI) was obtained on neutrophils stained with polyclonal anti-LF antibodies and with AGM 2.29. The kinetics of LF expression during activation demonstrated a progressive increase in MFI within 45 min. No increase in MFI was documented when primed granulocytes were stained with MoAb AGM 10.14, thus indicating that the epitope recognized by AGM 10.14 is not exposed at the cell surface. Following membrane permeabilization, performed in order to analyse the binding of anti-LF MoAbs to cytoplasmic LF, a marked increase in MFI was obtained by staining granulocytes with both anti-LF MoAbs. Indirect immunofluorescence (IIF) analysis confirmed that AGM 2.29 and AGM 10.14 reacted with human granulocytes, showing a cytoplasmic pattern on formalin-acetone-fixed neutrophils and a perinuclear one on ethanol-fixed cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276523      PMCID: PMC1904733          DOI: 10.1046/j.1365-2249.1997.4351333.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.

Authors:  Richard M Novak; Betty A Donoval; Parrie J Graham; Lucy A Boksa; Gregory Spear; Ronald C Hershow; Hua Yun Chen; Alan Landay
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

2.  Lactoferrin-lipid A-lipopolysaccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14.

Authors:  D Caccavo; A Afeltra; S Pece; G Giuliani; M Freudenberg; C Galanos; E Jirillo
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.

Authors:  Domenico Caccavo; Amelia Rigon; Antonio Picardi; Sara Galluzzo; Marta Vadacca; Giovanni Maria Ferri; Antonio Amoroso; Antonella Afeltra
Journal:  Clin Rheumatol       Date:  2004-12-09       Impact factor: 2.980

Review 4.  Iron metabolism and the innate immune response to infection.

Authors:  Erin E Johnson; Marianne Wessling-Resnick
Journal:  Microbes Infect       Date:  2011-10-20       Impact factor: 2.700

5.  DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis.

Authors:  He Li; Yansong Xu; Xin Zhou; Taiyang Jin; Ziru Wang; Yuansong Sun; Haiping Wang; Datong Jiang; Chunlin Yin; Bing Shen; Kai Song
Journal:  Molecules       Date:  2022-06-17       Impact factor: 4.927

6.  Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions.

Authors:  Steve D Swain; Daniel W Siemsen; Laura K Nelson; Karen M Sipes; Angela J Hanson; Mark T Quinn
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

7.  The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation.

Authors:  Haruki Shida; Daigo Nakazawa; Yu Tateyama; Arina Miyoshi; Yoshihiro Kusunoki; Fumihiko Hattanda; Sakiko Masuda; Utano Tomaru; Tamihiro Kawakami; Tatsuya Atsumi; Akihiro Ishizu
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

8.  Tamm-Horsfall glycoprotein enhances PMN phagocytosis by binding to cell surface-expressed lactoferrin and cathepsin G that activates MAP kinase pathway.

Authors:  Syue-Cian Siao; Ko-Jen Li; Song-Chou Hsieh; Cheng-Han Wu; Ming-Chi Lu; Chang-Youh Tsai; Chia-Li Yu
Journal:  Molecules       Date:  2011-03-03       Impact factor: 4.411

9.  RANTES and chemotactic activity in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.

Authors:  Joanna Stanczyk; Marek L Kowalski; Janina Grzegorczyk; Barbara Szkudlinska; Marzanna Jarzebska; Marek Marciniak; Marek Synder
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

10.  ACTH- and cortisol-associated neutrophil modulation in coronary artery disease patients undergoing stent implantation.

Authors:  Margit Keresztes; Tamás Horváth; Imre Ocsovszki; Imre Földesi; Gyöngyi Serfőző; Krisztina Boda; Imre Ungi
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.